|
VRK2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.995200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.567800E-01 |
| Normal-vs-Stage2 |
6.021600E-01 |
| Normal-vs-Stage3 |
1.357160E-01 |
| Normal-vs-Stage4 |
6.035600E-01 |
| Stage1-vs-Stage2 |
3.167200E-01 |
| Stage1-vs-Stage3 |
2.444000E-02 |
| Stage1-vs-Stage4 |
4.679200E-01 |
| Stage2-vs-Stage3 |
4.713200E-01 |
| Stage2-vs-Stage4 |
8.096800E-01 |
| Stage3-vs-Stage4 |
7.788800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.256200E-01 |
| Normal-vs-AfricanAmerican |
9.382400E-01 |
| Normal-vs-Asian |
2.298600E-01 |
| Caucasian-vs-AfricanAmerican |
9.884000E-01 |
| Caucasian-vs-Asian |
9.210300E-02 |
| AfricanAmerican-vs-Asian |
1.434170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.416420E-01 |
| Normal-vs-Female |
8.822300E-04 |
| Male-vs-Female |
1.57229999997455E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.256800E-01 |
| Normal-vs-Extreme_Weight |
8.693600E-02 |
| Normal-vs-Obese |
3.778800E-01 |
| Normal-vs-Extreme_Obese |
5.677600E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.456820E-01 |
| Normal_Weight-vs-Obese |
5.278000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.198600E-01 |
| Extreme_Weight-vs-Obese |
2.745900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.169000E-01 |
| Obese-vs-Extreme_Obese |
1.342630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.574100E-02 |
| Normal-vs-Age(41-60Yrs) |
3.679600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.445400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.697960E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.097960E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.552400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.361800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.007600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.442600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.857800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.845410E-01 |
| Normal-VS-Type2 PRCC |
7.972800E-01 |
| Normal-VS-KIRP CIMP |
1.423460E-03 |
| Normal-VS-Unclassified PRCC |
1.054800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.185000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.787900E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.737900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.00790000001627E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
7.623600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.479240E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.950500E-02 |
| Normal-vs-N1 |
4.622900E-03 |
| Normal-vs-N2 |
3.699000E-01 |
| N0-vs-N1 |
4.404100E-04 |
| N0-vs-N2 |
1.665030E-01 |
| N1-vs-N2 |
3.648600E-01 |
|
|
